|Product Name||3-(3,3-dimethylureido)phenyl dimethylcarbamate|
3-(3,3-dimethylureido)phenyl dimethylcarbamate product with CAS number NA and catalog number SA19712 is related to Neostigmine. This product is used for Abbreviated New Drug Application (ANDA) filing to FDA as well as for Quality Control (QC), toxicity studies and other analytical studies during commercial production of Neostigmine.
Neostigmine is the medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.
All products / Impurities / standards are provided with certificate of analysis (CoA) along with the characterization data like 1H-NMR, MASS, HPLC Purity etc. (whatever relevant and possible). Moreover, additional data like 13C-NMR, 13C-DEPT NMR, GC, GC-MS, IC, Potency, TGA, etc. will be provided on request (extra charges may apply).
This product is for research and development (R&D) use only.
If you need different pack size or different product, please contact us.
SynThink can provide products and pack size as per your requirement.
While sending enquiry / request please provide all available details with you like – CAS number, Structure, Common Name, Scientific Name, SynThink Catalog number, required quantity.
Keywords : Price of 3-(3,3-dimethylureido)phenyl dimethylcarbamate, manufacturer of 3-(3,3-dimethylureido)phenyl dimethylcarbamate , Price of NA, 3-(3,3-dimethylureido)phenyl dimethylcarbamate supplier, Neostigmine impurity manufacturer, Neostigmine Related compound, Neostigmine API Impurity, Neostigmine EP Impurity, NA, SA19712.